Cipla informs about press release

15 Jun 2021 Evaluate

Cipla has informed that it has enclosed press release announced by its step-down associate company in USA, Avenue Therapeutics Inc on 15th June 2021, titled ‘Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramado’.

The above information is a part of company’s filings submitted to BSE.


Cipla Share Price

1500.00 -7.25 (-0.48%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×